Keysight Technologies Inc. Stock Slides 5.6%, Underperforms Peers
Dow Jones2026/08/18 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Keysight Technologies Inc. slipped 5.6% to $341.00 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.7% to 7,691.76 and Dow Jones Industrial Average falling 0.2% to 53,343.40.
The stock's fall snapped a two-day winning streak.
Keysight Technologies Inc. closed 9.1% below its 52-week high of $374.96, which the company reached on June 22nd.
The stock underperformed when compared to some of its peers, as Emerson Electric Co. fell 2.6% to $157.78, Agilent Technologies Inc. remained unchanged, and Rockwell Automation Inc. fell 2.46% to $433.67.
Trading volume totaled 3.2 million, compared to the 50-day average of 1.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 18, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Fogo Foundation Attacked, Approximately 400 Million FOGO Tokens Transferred
Crypto prices
More
